Get used to that headline. Increased sales of food during the coming year are expected to contribute 1.5% to Target’s same-store sales growth as the company continues it aggressive PFresh remodeling program.

Target is expected to gain about $3 billion in market share during the next few years as the company completes the rollout of its PFresh program, according to Credit Suisse analyst Edward Kelly.

An over-the-counter version of the antihistamine Allegra hit the marketplace this past Friday amid a promotional frenzy that was consistent with the approach taken when similar products such as Claritin and Zyrtec became available without a prescription. As was the case with other products before it, retailers are eager to get their share of sales so there tends to be considerable activity around the launch.

The solid fourth-quarter financial results Target reported last week were quickly overshadowed by long-term growth objectives that gave stakeholders a clear idea of where the company is headed in terms of sales and profits. Target expects its annual sales, currently about $66 billion, to reach the $100 billion mark within six to seven years, and current earnings per share of $4 will at least double over that same time frame.

If those goals sound lofty and the time frame ambitious, it’s worth reviewing some of the growth drivers the company has in place and those which are yet to take hold.